Petros Pharmaceuticals, Inc. (PTPI): Total Liabilities
$2.29M
As of 2025-12-31
$2.84M
As of 2026-06-30
-47.4%
3-year compound annual growth
-46.5%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.29M | -87.3% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $18.10M | -15.1% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $21.32M | +35.6% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $15.72M | -50.6% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $31.85M | -39.2% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $52.38M | n/a | 2022-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | $2.29M | -87.3% |
| Polaryx Therapeutics, Inc. (PLYX) | 2025-12-31 | $605.0K | +109.3% |
| Azitra, Inc. (AZTR) | 2025-12-31 | $1.22M | -26.3% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $4.69M | -37.6% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.99M | +10.1% |
| International Stem Cell Corp (ISCO) | 2025-12-31 | $4.58M | -4.7% |
| AEON Biopharma, Inc. (AEON) | 2025-12-31 | $60.59M | +91.1% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $7.40M | +264.3% |
| CDT Equity Inc. (CDT) | 2025-12-31 | $12.82M | +16.7% |
Compare PTPI, PLYX, AZTR, QUCY side by side · Screen every company in Pharmaceutical Preparations ↗